NASDAQ : ONCY
Oncolytics Biotech Inc. — Financial statements
Healthcare · Biotechnology · Canada
Last price 0.4254 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 54.24M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 20.30M | 15.41M | 10.10M | 12.18M | 8.49M | 10.52M |
| Research & Development | 17.41M | 13.31M | 15.44M | 13.41M | 11.40M | 10.21M |
| Operating Expenses | 37.71M | 28.73M | 25.54M | 25.59M | 19.89M | 20.73M |
| Operating Income | -37.71M | -28.73M | -25.54M | -25.59M | -19.89M | -20.73M |
| Interest & Investment Income | 250.00K | 386.00K | 975.00K | 1.00M | 390.12K | 78.23K |
| Currency Exchange Gain (Loss) | 126.00K | -106.00K | 699.00K | -359.68K | 1.23M | -107.47K |
| Other Non Operating Income (Expenses) | -235.00K | 1.17M | 4.00M | -14.78K | 13.43K | |
| EBT Excluding Unusual Items | -37.34M | -28.68M | -22.70M | -20.94M | -18.29M | -20.75M |
| Pretax Income | -37.34M | -28.68M | -22.70M | -20.94M | -18.29M | -20.75M |
| Income Tax Expense | 119.00K | 79.00K | 95.00K | 73.45K | 62.06K | 38.72K |
| Net Income | -37.46M | -28.76M | -22.79M | -21.01M | -18.35M | -20.79M |
| Net Income to Common | -37.46M | -28.76M | -22.79M | -21.01M | -18.35M | -20.79M |
| Shares Outstanding (Basic) | 109.96M | 95.86M | 76.48M | 67.62M | 58.03M | 53.51M |
| Shares Outstanding (Diluted) | 109.96M | 95.86M | 76.48M | 67.62M | 58.03M | 53.51M |
| EPS (Basic) | -0.34 | -0.30 | -0.30 | -0.31 | -0.32 | -0.39 |
| EPS (Diluted) | -0.34 | -0.30 | -0.30 | -0.31 | -0.32 | -0.39 |
| Free Cash Flow | -26.71M | -20.12M | -20.06M | -21.55M | -17.30M | -17.95M |
| Free Cash Flow Per Share | -0.24 | -0.21 | -0.26 | -0.32 | -0.30 | -0.34 |
| EBITDA | -37.65M | -28.66M | -25.45M | -25.53M | -19.82M | -20.63M |
| D&A For EBITDA | 64.00K | 70.00K | 87.00K | 61.33K | 68.72K | 102.73K |
| EBIT | -37.71M | -28.73M | -25.54M | -25.59M | -19.89M | -20.73M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.12M | 5.20M | 11.08M | 26.44M | 8.62M | 32.61M |
| Short-Term Investments | 15.13M | |||||
| Cash & Short-Term Investments | 4.12M | 5.20M | 11.08M | 26.44M | 23.75M | 32.61M |
| Other Receivables | 1.21M | 573.00K | 47.00K | 11.36K | 24.38K | 66.38K |
| Receivables | 1.21M | 573.00K | 47.00K | 11.36K | 24.38K | 66.38K |
| Prepaid Expenses | 1.74M | 1.07M | 1.31M | 2.46M | 1.25M | 2.19M |
| Other Current Assets | 1.34M | 617.94K | ||||
| Total Current Assets | 7.07M | 6.84M | 12.44M | 28.91M | 26.37M | 35.48M |
| Property, Plant & Equipment | 602.00K | 738.00K | 985.00K | 489.92K | 481.74K | 771.24K |
| Other Long-Term Assets | 737.39K | |||||
| Total Assets | 7.67M | 7.58M | 13.42M | 29.40M | 27.58M | 36.25M |
| Accounts Payable | 3.40M | 3.50M | 756.00K | 819.31K | 1.66M | 469.38K |
| Accrued Expenses | 1.68M | 2.33M | 2.57M | 1.89M | 1.03M | 1.10M |
| Current Portion of Leases | 138.00K | 193.00K | 200.00K | 100.71K | 159.60K | 232.32K |
| Other Current Liabilities | 77.00K | 1.35M | 402.84K | 58.37K | 322.40K | |
| Total Current Liabilities | 5.22M | 6.10M | 4.88M | 3.21M | 2.91M | 2.13M |
| Long-Term Leases | 310.00K | 370.00K | 561.00K | 219.59K | 116.00K | 285.26K |
| Long-Term Unearned Revenue | 4.91M | 4.91M | 4.68M | 5.10M | 4.97M | 5.32M |
| Other Long-Term Liabilities | 3.39M | |||||
| Total Liabilities | 13.84M | 11.38M | 10.12M | 8.52M | 8.00M | 7.73M |
| Common Stock | 326.29M | 298.53M | 309.25M | |||
| Additional Paid-In Capital | 435.79M | 419.47M | 397.67M | 31.89M | 29.59M | 26.99M |
| Retained Earnings | -448.18M | -429.50M | -400.74M | -337.72M | -309.03M | -310.88M |
| Comprehensive Income & Other | 6.22M | 6.22M | 6.36M | 411.93K | 489.13K | 3.17M |
| Shareholders' Equity | -6.17M | -3.80M | 3.30M | 20.87M | 19.58M | 28.53M |
| Total Liabilities & Equity | 7.67M | 7.58M | 13.42M | 29.40M | 27.58M | 36.25M |
| Total Debt | 448.00K | 563.00K | 761.00K | 320.30K | 275.60K | 517.59K |
| Net Cash (Debt) | 3.67M | 4.64M | 10.32M | 26.12M | 23.47M | 32.09M |
| Net Cash Per Share | 0.03 | 0.05 | 0.13 | 0.39 | 0.40 | 0.60 |
| Filing Date Shares Outstanding | 127.51M | 116.13M | 86.42M | 75.42M | 62.83M | 57.11M |
| Total Common Shares Outstanding | 124.64M | 108.02M | 80.02M | 74.42M | 61.33M | 55.04M |
| Working Capital | 1.84M | 743.00K | 7.55M | 25.70M | 23.45M | 33.36M |
| Book Value Per Share | -0.05 | -0.04 | 0.04 | 0.28 | 0.32 | 0.52 |
| Tangible Book Value | -6.17M | -3.80M | 3.30M | 20.87M | 19.58M | 28.53M |
| Tangible Book Value Per Share | -0.05 | -0.04 | 0.04 | 0.28 | 0.32 | 0.52 |
| Machinery | 620.00K | 597.00K | 564.88K | 546.02K | 541.29K | |
| Leasehold Improvements | 134.00K | 128.00K | 174.92K | 170.68K | 180.17K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -37.46M | -28.76M | -22.79M | -21.01M | -18.35M | -20.79M |
| Depreciation & Amortization | 64.00K | 70.00K | 87.00K | 305.16K | 289.64K | 357.17K |
| Stock-Based Compensation | 9.45M | 6.57M | 1.98M | 1.57M | 1.76M | 3.02M |
| Other Operating Activities | 1.30M | 826.00K | -1.68M | -3.73M | -1.24M | 395.89K |
| Change in Accounts Receivable | -635.00K | 3.00K | -39.00K | 383.15K | 254.91K | -613.20K |
| Change in Accounts Payable | 2.50M | 2.93M | 4.00K | -59.06K | 1.23M | 144.61K |
| Change in Other Net Operating Assets | -1.92M | -1.75M | 2.56M | 1.01M | -1.19M | -248.91K |
| Operating Cash Flow | -26.70M | -20.11M | -19.88M | -21.54M | -17.26M | -17.73M |
| Capital Expenditures | -11.00K | -6.00K | -174.00K | -6.06K | -40.64K | -226.00K |
| Investment in Securities | 15.32M | -15.03M | ||||
| Investing Cash Flow | -11.00K | -6.00K | -174.00K | 15.31M | -15.08M | -226.00K |
| Long-Term Debt Repaid | -308.19K | -281.51K | -289.22K | |||
| Lease Payments | -308.19K | -281.51K | -289.22K | |||
| Net Debt Issued (Repaid) | -308.19K | -281.51K | -289.22K | |||
| Issuance of Common Stock | 21.02M | 14.91M | 5.03M | 24.53M | 9.86M | 27.37M |
| Other Financing Activities | -789.00K | -789.00K | -564.50K | -992.50K | ||
| Financing Cash Flow | 20.23M | 14.12M | 5.03M | 24.23M | 9.02M | 26.09M |
| Foreign Exchange Rate Adjustments | -119.00K | 121.00K | -289.00K | -395.27K | 1.45M | -200.71K |
| Net Cash Flow | -6.61M | -5.88M | -15.32M | 17.60M | -21.87M | 7.94M |
| Free Cash Flow | -26.71M | -20.12M | -20.06M | -21.55M | -17.30M | -17.95M |
| Free Cash Flow Per Share | -0.24 | -0.21 | -0.26 | -0.32 | -0.30 | -0.34 |
| Levered Free Cash Flow | -12.01M | -10.38M | -11.33M | -13.74M | -9.37M | -10.74M |
| Unlevered Free Cash Flow | -12.01M | -10.38M | -11.33M | -13.74M | -9.37M | -10.74M |
| Free Cash Flow After Leases | -26.71M | -20.12M | -20.06M | -21.86M | -17.58M | -18.24M |
| Cash Income Tax Paid | 107.00K | 67.00K | 134.00K | 90.87K | 33.99K | 27.66K |
| Change in Working Capital | -59.00K | 1.18M | 2.52M | 1.34M | 288.90K | -717.51K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 53.36M | 94.05M | 70.43M | 99.78M | 96.22M | 76.49M |
| Enterprise Value | 49.70M | 85.78M | 56.71M | 70.61M | 72.98M | 39.02M |
| Last Close Price | 0.43 | 0.87 | 0.91 | 1.35 | 1.63 | 1.39 |
| PB Ratio | -24.76 | 21.36 | 4.78 | 4.91 | 2.68 | |
| P/TBV Ratio | 21.36 | 4.78 | 4.91 | 2.68 | ||
| Debt / Equity Ratio | -0.07 | -0.15 | 0.23 | 0.01 | 0.01 | 0.02 |
| Net Debt / Equity Ratio | 0.59 | 1.22 | -3.13 | -1.25 | -1.20 | -1.12 |
| Net Debt / EBITDA Ratio | 0.10 | 0.16 | 0.41 | 1.02 | 1.18 | 1.56 |
| Net Debt / FCF Ratio | 0.14 | 0.23 | 0.51 | 1.21 | 1.36 | 1.79 |
| Quick Ratio | 1.02 | 0.95 | 2.28 | 8.24 | 8.15 | 15.37 |
| Current Ratio | 1.35 | 1.12 | 2.55 | 9.01 | 9.04 | 16.69 |
| Return on Equity (ROE) | -203.03% | -102.66% | -79.34% | -86.45% | ||
| Return on Assets (ROA) | -211.24% | -170.96% | -79.03% | -55.46% | -40.44% | -40.88% |
| Return on Capital Employed (ROCE) | -1,541.80% | -1,939.60% | -299.20% | -97.70% | -80.60% | -60.70% |
| Earnings Yield | -81.40% | -30.58% | -32.36% | -21.06% | -19.07% | -27.18% |
| FCF Yield | -49.25% | -21.39% | -28.48% | -21.59% | -17.98% | -23.47% |
| Buyback Yield / Dilution | -33.18% | -25.33% | -13.10% | -16.53% | -8.44% | -32.66% |